Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Дек. 9, 2024
Colorectal
cancer
(CRC)
is
a
leading
cause
of
cancer-related
deaths
globally.
The
heterogeneity
the
tumor
microenvironment
significantly
influences
patient
prognosis,
while
diversity
cells
shapes
its
unique
characteristics.
A
comprehensive
analysis
molecular
profile
crucial
for
identifying
novel
targets
drug
sensitivity
and
uncovering
pathophysiological
mechanisms
underlying
CRC.
Macromolecules,
Год журнала:
2024,
Номер
57(6), С. 2858 - 2867
Опубликована: Март 14, 2024
Aliphatic
polycarbonates
(APCs)
are
promising
biocompatible
and
degradable
polymers
with
immense
potential
for
biomedical
applications.
However,
current
synthetic
approaches
to
stimuli-responsive
APCs
remain
limited
often
complicated,
requiring
multiple-step
postpolymerization
reactions.
To
address
these
limitations
unlock
the
full
of
in
development
advanced
biomaterials,
we
developed
a
rapid
versatile
strategy
synthesize
glutathione
(GSH)-responsive
through
controlled
ring-opening
polymerization
cyclic
carbonates
activated
disulfides.
Responsive
pendant
moieties
could
be
easily
introduced
one
step
highly
efficient
thiol–disulfide
exchange
reaction
enabled
by
reactive
pyridyl
disulfides,
providing
simple
approach
fine-tuning
polymer's
physiochemical
properties
As
proof
concept,
prepared
an
amphiphilic
GSH-responsive
polycarbonate-drug
conjugate
initiating
carbonate
monomer
methyl
polyethylene
glycol
then
conjugating
anticancer
drug
mertansine
via
reaction.
The
self-assembled
nanoparticles
were
smart
delivery
system
GSH-triggered
release
specifically
within
cancer
cells
remarkable
selective
toxicity
toward
over
healthy
cells,
showcasing
exceptional
promise
this
polycarbonate
Senescent
cancer
cells
are
endowed
with
high
immunogenic
potential
that
has
been
leveraged
to
elicit
antitumor
immunity
and
potentially
complement
anticancer
therapies.
However,
the
efficacy
of
live
senescent
cell-based
vaccination
is
limited
by
interference
from
immunosuppressive
senescence-associated
secretory
phenotype
pro-tumorigenic
capacity
cells.
Here,
a
nanovaccine
strong
immunogenicity
favorable
for
immunotherapy
reported.
The
biomimetic
integrating
cell
membrane-coated
nanoadjuvant
outperforms
living
in
enhancing
dendritic
(DCs)
internalization,
improving
lymph
node
targeting,
immune
responses.
In
contrast
nanovaccines
generated
death-induced
tumor
cells,
facilitate
DC
maturation,
eliciting
superior
protection
therapeutic
outcomes
melanoma-challenged
mice
fewer
side
effects
when
combined
αPD-1.
study
suggests
versatile
biomanufacturing
approach
maximize
minimize
adverse
advances
design
immunotherapy.
Frontiers in Immunology,
Год журнала:
2025,
Номер
15
Опубликована: Янв. 17, 2025
High-grade
serous
ovarian
cancer
(HGSOC),
the
predominant
subtype
of
epithelial
cancer,
is
frequently
diagnosed
at
an
advanced
stage
due
to
its
nonspecific
early
symptoms.
Despite
standard
treatments,
including
cytoreductive
surgery
and
platinum-based
chemotherapy,
significant
improvements
in
survival
have
been
limited.
Understanding
molecular
mechanisms,
immune
landscape,
drug
sensitivity
HGSOC
crucial
for
developing
more
effective
personalized
therapies.
This
study
integrates
insights
from
immunology,
profiling,
analysis
identify
novel
therapeutic
targets
improve
treatment
outcomes.
Utilizing
single-cell
RNA
sequencing
(scRNA-seq),
systematically
examines
tumor
heterogeneity
microenvironment,
focusing
on
biomarkers
influencing
response
activity,
aiming
enhance
patient
outcomes
quality
life.
scRNA-seq
data
was
obtained
GEO
database
this
study.
Differential
gene
expression
analyzed
using
ontology
set
enrichment
methods.
InferCNV
identified
malignant
cells,
while
Monocle,
Cytotrace,
Slingshot
software
inferred
differentiation
trajectories.
The
CellChat
package
predicted
cellular
communication
between
cell
subtypes
other
pySCENIC
utilized
transcription
factor
regulatory
networks
within
subtypes.
Finally,
results
were
validated
through
functional
experiments,
a
prognostic
model
developed
assess
prognosis,
infiltration,
across
various
risk
groups.
investigated
scRNA-seq,
their
interactions
microenvironment.
We
confirmed
key
role
C2
IGF2+
HGSOC,
which
significantly
associated
with
poor
prognosis
high
levels
chromosomal
copy
number
variations.
located
terminal
tumor,
displaying
higher
degree
malignancy
close
association
IIIC
tissue
types.
also
metabolic
pathways,
such
as
glycolysis
riboflavin
metabolism,
well
programmed
death
processes.
highlighted
complex
fibroblasts
MK
signaling
pathway,
may
be
closely
related
tumor-associated
progression.
Elevated
PRRX1
connected
impact
disease
progression
by
modulating
transcription.
A
based
demonstrated
adverse
outcomes,
emphasizing
importance
infiltration
clinical
intervention
strategies.
oncology,
immunotherapy,
reveal
mechanisms
driving
resistance.
subtype,
linked
offers
promising
target
future
Emphasizing
sensitivity,
research
highlights
strategies
life
patients.
Advanced Functional Materials,
Год журнала:
2024,
Номер
34(44)
Опубликована: Май 25, 2024
Abstract
The
vigorous
development
of
cancer
nanomedicine
has
revolutionized
traditional
oncology
medicine,
but
it
is
also
limited
by
the
continuous
mutation
cunning
cells,
leading
to
apoptosis
insensitivity
and
therapeutic
disappointment.
Inflammatory‐regulated
cell
death
(RCD),
especially
pyroptosis‐related
death,
demonstrates
huge
potential
for
sensitization
due
its
unique
biochemical
characteristics.
aim
this
research
present
a
thorough
synopsis
current
knowledge
on
pyroptosis‐associated
inflammatory
including
pyroptosis,
cuproptosis,
PANoptosis,
synergistic
function
in
nano
therapy.
Paradigm
studies
death‐mediated
apoptosis‐sensitizing
tumor
nanotherapeutics
are
introduced
detail,
coordination
mechanisms
based
nanomaterials
discussed.
In
addition,
multi‐angle
analysis
future
prospects
pyroptosis‐sensitized
various
emphasized
further
expand
application
scope
RCD.
It
believed
that
emerging
auxiliary
treatments
RCD
will
greatly
promote
progress
nanomedicine.
Abstract
Universal
protein
coatings
have
recently
gained
wide
interest
in
medical
applications
due
to
their
biocompatibility
and
ease
of
fabrication.
However,
the
challenge
persists
activity
preservation,
significantly
complicating
functional
design
these
coatings.
Herein,
an
active
dual‐protein
surface
engineering
strategy
assisted
by
a
facile
stepwise
protein–protein
interactions
assembly
(SPPIA)
method
for
catheters
reduce
clot
formation
infection
is
proposed.
This
realized
first
partial
oxidation
bovine
serum
albumin
(BSA)
lysozyme
(LZM)
creating
stable
nucleation
platforms
via
hydrophobic
interaction,
followed
nonoxidized
BSA
(pI,
isoelectric
point,
≈4.7)
LZM
(pI
≈11)
through
electrostatic
interaction
owing
opposite
charge
under
neutral
conditions.
The
SPPIA
effectively
preserves
conformation
functionality
both
LZM,
thus
endowing
resultant
coating
with
potent
antithrombotic
bactericidal
properties.
Furthermore,
platform
ensures
adhesion
durability
coating,
resisting
thrombosis
bacterial
proliferation
even
after
15
days
PBS
immersion.
Overall,
approach
not
only
provides
new
fabrication
but
also
shows
promise
technology
catheters.
Achieving
antitumor
immunotherapy
based
on
hybridization
of
multiple
types
inactivated
cells
has
attracted
a
lot
attention.
However,
the
hybridized
disordered
structure
could
result
in
shedding
antigens
and
their
transfer
to
immune
cells,
which
suppresses
tumor
immunity
through
trogocytosis.
Here,
we
report
strategy
for
situ
solidification
whole
cell
by
biomineralization
sustained
stimulation
immunity.
The
near-infrared
light
was
used
accelerate
breaking
Au=P
bonds
auranofin,
exposed
Au
atoms
biomineralize
at
secondary
(β-corner)
protein
form
nanocrystals
with
coronas
cells.
are
anchored
coronas,
fixes
morphology
rendering
them
physiologically
inactive.
Interestingly,
this
solidified
prevents
from
undergoing
trogocytosis,
inhibits
proximal
distal
growth.
Thus,
study
presents
its
potential
application
immunotherapy.
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
13(18)
Опубликована: Апрель 4, 2024
The
major
bottleneck
in
using
polymer
nanovectors
for
biomedical
application,
particularly
those
based
on
self-immolative
poly(amino
ester)
(PAE),
lies
their
uncontrolled
autodegradation
at
physiological
pH
before
they
can
reach
the
intended
target.
Here,
an
elegant
triblock-copolymer
strategy
is
designed
to
stabilize
unstable
PAE
chains
via
zwitterionic
interactions
under
(pH
7.4)
and
precisely
program
enzyme-responsive
biodegradation
specifically
within
intracellular
compartments,
ensuring
targeted
delivery
of
cargoes.
To
achieve
this
goal,
biodegradable
polycaprolactone
(PCL)
platform
chosen,
structure-engineered
several
di-
triblock
architectures
arrive
precise
macromolecular
geometry.
hydrophobic-PCL
core
hydrophilic
anionic-PCL
block
periphery
shield
PAEs
against
autodegradation,
thereby
stability
PBS,
FBS,
cell
culture
medium
bloodstream.
clinical
anticancer
drug
doxorubicin
deep-tissue
penetrable
near-infrared
IR-780
biomarker
encapsulated
study
biological
actions
by
vitro
live
cancer
cells
vivo
bioimaging
animals.
These
zwitterions
are
biocompatible,
nonhemolytic,
real-time
live-cell
confocal
studies
have
confirmed
internalization
enzymatic
endo-lysosomal
compartments
deliver
payload.
In
establishes
prolonged
blood
circulation
over
72
h,
biodistribution
analysis
reveals
accumulation
nanoparticles
predominantly
excretory
organs.
Frontiers in Oncology,
Год журнала:
2025,
Номер
14
Опубликована: Янв. 21, 2025
Hepatocellular
carcinoma
(HCC)
is
one
of
the
most
common
lethal
cancers
worldwide.
Natural
killer
cells
(NK
cells)
play
a
key
role
in
liver
immunosurveillance,
but
tumor
microenvironment,
NK
are
readily
depleted,
as
evidenced
by
down-regulation
activating
receptors,
reduced
cytokine
secretion,
and
attenuated
killing
function.
The
up-regulation
inhibitory
such
PD-1,
TIM-3,
LAG-3,
further
exacerbates
depletion
cells.
Combined
blockade
strategies
targeting
these
immunosuppressive
mechanisms,
combination
PD-1
inhibitors
with
other
pathways
(eg.
TIM-3
LAG-3),
have
shown
potential
to
reverse
cell
exhaustion
preclinical
studies.
This
article
explores
promise
innovative
HCC
immunotherapy,
providing
new
therapeutic
directions
for
optimizing
function
improving
drug
sensitivity.
Cell
membrane
coating
has
emerged
as
a
promising
strategy
for
the
surface
modification
of
biomaterials
with
biological
membranes,
serving
cloak
that
can
carry
more
functions.
The
cloaked
inherit
diverse
intrinsic
biofunctions
derived
from
different
cell
sources,
including
enhanced
biocompatibility,
immunity
evasion,
specific
targeting
capacity,
and
immune
regulation
regenerative
microenvironment.
characteristics
biomimicry
biointerfacing
have
demonstrated
versatility
technology
on
variety
biomaterials,
thus,
furthering
research
into
wide
range
biomedical
applications
clinical
translation.
Here,
preparation
coatings
is
emphasized,
sizes
coated
nanoscale
to
macroscale
well
engineering
strategies
introduce
additional
are
summarized.
Subsequently,
utilization
biomimetic
membrane-cloaked
in
discussed,
drug
delivery,
imaging
phototherapy,
cancer
immunotherapy,
anti-infection
detoxification,
implant
modification.
In
conclusion,
latest
advancements
preclinical
studies,
along
multiple
benefits
membrane-coated
nanoparticles
(NPs)
systems,
elucidated.